EUVIMEDDescubrir EUVIMED
Crossref

Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone

Lais R R Costa, Cyprianna Swiderski, Carrie Palm, Monica Aleman iD

Journal of Veterinary Emergency and Critical Care · 2023

DOI: 10.1111/vec.13314 ↗

At a glance

Journal article in Journal of Veterinary Emergency and Critical Care, 2023. Written by Lais R R Costa and 3 co-authors. Institution: Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA. Major MEDLINE topics: Anti-Inflammatory Agents, Non-Steroidal, Hepatitis A virus. Cited 2 times so far (Crossref); 17 references.

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

Objectives

To investigate if hepatitis A virus cell receptor 1/kidney injury molecule 1 (HAVCR1/KIM1) in urine is detectable concurrently with increases in serum creatinine concentrations in horses receiving a recommended dose of phenylbutazone (PBZ) for 7 days.

Design

Preliminary study.

Methods

Ten clinically healthy horses with normal physical examination and laboratory work were randomly assigned to PBZ or placebo groups (5 each). The PBZ group received PBZ at 4.4 mg/kg mixed with corn syrup orally every 12 hours. The placebo group received corn syrup orally every 12 hours. Both groups were treated for 7 days. Kidney ultrasonography was performed, and venous blood and urine samples were collected prior to commencement and at the end of treatment. Samples from 1 additional healthy horse, 3 horses with acute kidney failure, and 1 horse with chronic kidney failure were also evaluated.

Results

None of the 10 horses had detectable HAVCR1/KIM1 in urine at baseline. Serum creatinine concentrations in placebo group did not increase, and HAVCR1/KIM1 was undetectable in urine. At the end of treatment, 3 of 5 horses receiving PBZ developed increases in serum creatinine of >26.5 μmol/L (>0.3 mg/dL), and HAVCR1/KIM1 was detectable in urine, despite normal findings on kidney ultrasonography in all horses.

Conclusions

HAVCR1/KIM1 is detectable in urine and is associated with increases in serum creatinine concentrations of >26.5 μmol/L in horses following treatment with PBZ for 7 consecutive days. Thus, HAVCR1/KIM1 might aid in the early detection of acute kidney injury in horses.

Subjects

MeSH terms (MEDLINE)

Anti-Inflammatory Agents, Non-SteroidalHepatitis A virusHorsesAnimalsCreatininePhenylbutazoneKidney

Author keywords

anti-inflammatoriesbiomarkersequinerenal

Substances

Anti-Inflammatory Agents, Non-SteroidalCreatininePhenylbutazone

Authors and institutions

  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, Davis, California, USA.
  • Department of Pathobiology and Population Medicine, School of Veterinary Medicine, Mississippi State University, Mississippi State, Mississippi, USA.

ORCID profiles: Monica Aleman

Cite

APA

Costa, L. R. R., Swiderski, C., Palm, C., & Aleman, M. (2023). Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone. Journal of Veterinary Emergency and Critical Care. https://doi.org/10.1111/vec.13314

Vancouver

Costa LRR, Swiderski C, Palm C, Aleman M. Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone. Journal of Veterinary Emergency and Critical Care. 2023. doi:10.1111/vec.13314

BibTeX
@article{Costa2023,
  author = {Costa, Lais R R and Swiderski, Cyprianna and Palm, Carrie and Aleman, Monica},
  title = {Preliminary evaluation of hepatitis A virus cell receptor 1/kidney injury molecule 1 in healthy horses treated with phenylbutazone},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2023},
  doi = {10.1111/vec.13314}
}
Start for free →